Deutsche Bank has upgraded CVS Health (NYSE:CVS) to buy from hold, asserting that the company’s earnings and business multiple are "now likely near trough levels" while it has taken measures to improve profitability.

Shares of healthcare giant CVS Health Corp (NYSE:CVS) are 1.5% higher before the bell, after a bull note at Deutsche Bank. The analyst in question upgraded CVS to "buy" from "hold" and maintained its $66 price target, saying the company's earnings will recover and beat expectations.

Analysts have set 12-month price targets for CVS Health, revealing an average target of $68.83, a high estimate of $85.00, and a low estimate of $58.00. Surpassing the previous average price target of $66.78, the current average has increased by 3.07%.

Although nearly 40 people were home at the time of the blaze, Weston firefighters said no injuries were reported. The $4M+ home is a total loss. Senator Ted Cruz (R-TX) hit Morning Joe co-hosts Joe Scarborough and Mika Brzezinski below the belt with a vulgar insult saying they’d kissed the President-elect Donald Trump “a little bit lower” than “the ring” at their recent visit to Mar-a-Lago.

Fintel reports that on December 3, 2024, Deutsche Bank upgraded their outlook for CVS Health (NYSE:CVS) from Hold to Buy. Analyst Price Forecast Suggests 15.72% Upside As of December 2, 2024, the average one-year price target for CVS Health is $68.